FDA OKs First Multitarget Stool RNA Test for CRC Screening FDA OKs First Multitarget Stool RNA Test for CRC Screening

Relative to fecal immunochemical testing, the multitarget stool RNA test ColoSense showed a significant improvement in sensitivity for colorectal cancer and advanced adenomas.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Gastroenterology News Alert Source Type: news